Sign In
Buy ILMN
$170.93
+8.38 (+5.16%)
At Close: Jun 03, 2026
Illumina to Cut $100 Million in Costs, Lowers Guidance Because of China Sales Ban
04:01pm, Monday, 10'th Mar 2025
Beijing banned imports of Illumina's gene-sequencing machines in response to U.S. tariffs.
Illumina leads as highest-scoring U.S. company in its industry SAN DIEGO , March 6, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies,
Illumina Stock Drops as China Bans Imports of Gene-Sequencing Technology
09:38am, Tuesday, 04'th Mar 2025
Illumina was placed on China's list of ‘unreliable entities' in February.
China bans imports of Illumina's gene sequencers
12:57am, Tuesday, 04'th Mar 2025
China announced a ban on Tuesday on imports of genetic sequencers from U.S. medical equipment maker Illumina , just minutes after U.S. President Donald Trump's additional 10% tariff on Chinese goods t
Here's Why Illumina (ILMN) is a Strong Value Stock
10:40am, Friday, 28'th Feb 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Illumina, Inc. (ILMN) AGBT Investor Session Conference (Transcript)
07:43pm, Tuesday, 25'th Feb 2025
Illumina, Inc. (NASDAQ:ILMN ) AGBT Investor Session Conference February 25, 2025 11:00 AM ET Company Participants Salli Schwartz - Head of Investor Relations Jacob Thaysen - Chief Executive Officer St
ILMN Stock Might Rise From Collaboration With Broad Clinical Labs
11:15am, Monday, 24'th Feb 2025
Illumina Collaborates with Broad Clinical Labs to set the standard for scalable single-cell research and accelerate discovery in areas such as disease modeling and drug development.
Illumina transforms multiomic research with new technologies to unlock deeper understanding of biology
09:15am, Monday, 24'th Feb 2025
Company expands multiomics portfolio with new roadmap technologies spanning genomics, spatial, single cell, CRISPR, and methylation, as well as a new multimodal data analysis platform Built on Illumin
Illumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly scale single-cell solutions
09:15am, Friday, 21'st Feb 2025
Longstanding partners bring together end-to-end workflows and leading CRISPRPerturb-seq technologies setting a standard for single-cell studies and enabling a 5billion single-cell atlas ecosystem with
Illumina unveils first-of-its-kind spatial transcriptomics technology
09:15am, Wednesday, 19'th Feb 2025
Broad Institute to collaborate on flagship project tapping Illumina's new spatial technology At AGBT, customers will present data demonstrating unparalleled scale and sensitivity in research spanning
Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference
04:05pm, Tuesday, 18'th Feb 2025
SAN DIEGO , Feb. 18, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that investors, analysts, and other interested parties can access a live webcast of its upcoming investor sessio
NVIDIA's Rise Puts These 3 Healthcare Stocks in the Spotlight
01:36pm, Tuesday, 18'th Feb 2025
ILMN, IQV and DXCM are leveraging AI advancements to drive innovation in genomics, clinical research and diabetes management.
Here's Why Illumina (ILMN) is a Strong Growth Stock
10:46am, Wednesday, 12'th Feb 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
ILMN vs. ALNY: Which Stock Is the Better Value Option?
12:40pm, Tuesday, 11'th Feb 2025
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Illumina (ILMN) and Alnylam Pharmaceuticals (ALNY). But which of these two stocks offers value inves
Why Illumina (ILMN) is a Top Value Stock for the Long-Term
10:40am, Tuesday, 11'th Feb 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
